Intimation of Schedule of Earnings Conference Call-Q4 and FY26

Board & Shareholder Meetings View source PDF

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.8%1-day move

₹251.61

prior close

₹253.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.4-0.2-0.8+4.8+5.7+11.7+7.3+9.7+11.4+10.0+2.5+10.0—

Up moveDown movePending

AI summary

Artemis Medicare Services has announced an earnings conference call scheduled for May 11, 2026 at 11:00 AM IST to discuss Q4 and FY26 operational and financial performance. The call will be hosted by Anand Rathi Research. Key participants include Managing Director Dr. Devlina Chakravarty, CFO Sanjiv Kumar Kothari, and Head of Investor Relations Rudra Narayan Acharjee. Dial-in details for India and international access have been provided. This is a routine regulatory intimation under SEBI LODR Regulation 30.

Likely market impact

This is a standard investor relations announcement and does not contain any material financial data or corporate actions. The actual Q4/FY26 results will be discussed during the call, so this filing itself carries no immediate impact on the stock.